Eric S. Daar

18.6k citations
239 papers · 11.5k · 4 hit papers · h-index 55

Impact in

  • Virology top 0.02%
    • HIV Research and Treatment
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment

Papers in

    • HIV/AIDS Research and Interventions 125
    • HIV/AIDS drug development and treatment 109
    • HIV Research and Treatment 144

Eric S. Daar

228 papers receiving 11.2k citations

Eric S. Daar's Hit Papers

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial 2017 · 257 citations
2570+11+23Years since publication250500750

Peers

Eric S. Daar
Comparison fields: 5 of 153
  • Virology 7.2k
  • Infectious Diseases 7.3k
  • Emergency Medicine 2.5k
  • Hepatology 756
  • Epidemiology 2.9k
Replace Joep M. A. Lange with:
Joep M. A. Lange Netherlands
Matthias Cavassini Switzerland
José M. Gatell Spain
Dominique Costagliola France
Ann C. Collier United States
Stefano Vella Italy
Susan J. Little United States
Jan Gerstoft Denmark
Sharon Walmsley Canada
Andrea Antinori Italy
Eric S. Daar relative to Joep M. A. Lange Netherlands Joep M. A. Lange's profile →
Citations per field
00.5×
Joep M. A. Lange · 1×
Citations per year

Countries citing papers authored by Eric S. Daar

Since Specialization
Citations

This map shows the geographic impact of Eric S. Daar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric S. Daar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric S. Daar more than expected).

Fields of papers citing papers by Eric S. Daar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric S. Daar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric S. Daar. The network helps show where Eric S. Daar may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric S. Daar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric S. Daar Line = papers co-authored together Eric S. Daar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
Hit paper breakdown →
2002878
2
Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection
Hit paper breakdown →
1991653
3
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
Hit paper breakdown →
2011381
4 1990372
5 2000355
6 1997283
7 2011262
8
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
Hit paper breakdown →
2017257
9 2005242
10 1991240
11 1996237
12 2011234
13 2009215
14 2001181
15 1992157
16 2014151
17 2010148
18 2001139
19 2011138
20 2007131

About Eric S. Daar

Eric S. Daar is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Immunology, having authored 239 papers that have together received 11.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (144 papers), HIV/AIDS Research and Interventions (125 papers), HIV/AIDS drug development and treatment (109 papers), HIV-related health complications and treatments (55 papers), HIV, Drug Use, Sexual Risk (24 papers), Immune Cell Function and Interaction (18 papers), Hepatitis C virus research (16 papers) and Cytomegalovirus and herpesvirus research (14 papers). The work is most often cited by research in Virology (7.2k citations), Infectious Diseases (7.3k citations), Emergency Medicine (2.5k citations), Hepatology (756 citations) and Epidemiology (2.9k citations). Eric S. Daar has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David D. Ho, Tarsem Moudgil, Susan J. Little, Richard D. Meyer, Douglas D. Richman, Paul E. Sax, Ann C. Collier, Camlin Tierney, Nicholas S. Hellmann and Nasreen C. Jahed. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, The Journal of Infectious Diseases, AIDS, Clinical Infectious Diseases and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact